VistaGen Therapeutics (VTGN) PT Raised to $7 at Jefferies
Get Alerts VTGN Hot Sheet
Price: $0.56 -3.45%
Rating Summary:
2 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
2 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Jefferies analyst Andrew Tsai raised the price target on VistaGen Therapeutics (NASDAQ: VTGN) to $7.00 (from $6.00) while maintaining a Buy rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Goldman Sachs Upgrades Plains All American (PAA) to Neutral
- Old Dominion Freight Line (ODFL) PT Raised to $233 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share